These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1318410)

  • 1. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.
    Rapp M; Messerle M; Bühler B; Tannheimer M; Keil GM; Koszinowski UH
    J Virol; 1992 Jul; 66(7):4399-406. PubMed ID: 1318410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus.
    Rapp M; Lucin P; Messerle M; Loh LC; Koszinowski UH
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():183-8. PubMed ID: 8113726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
    Cranage MP; Kouzarides T; Bankier AT; Satchwell S; Weston K; Tomlinson P; Barrell B; Hart H; Bell SE; Minson AC
    EMBO J; 1986 Nov; 5(11):3057-63. PubMed ID: 3024973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and molecular characterization of the murine cytomegalovirus homolog of the human cytomegalovirus UL100 gene.
    Li W; Eidman K; Gehrz RC; Kari B
    Virus Res; 1995 May; 36(2-3):163-75. PubMed ID: 7653096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.
    Britt WJ; Vugler L; Butfiloski EJ; Stephens EB
    J Virol; 1990 Mar; 64(3):1079-85. PubMed ID: 2154594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product.
    Loh LC; Britt WJ; Raggo C; Laferté S
    Virology; 1994 May; 200(2):413-27. PubMed ID: 8178431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus.
    Xu J; Lyons PA; Carter MD; Booth TW; Davis-Poynter NJ; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():49-59. PubMed ID: 8558128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity.
    Gönczöl E; deTaisne C; Hirka G; Berencsi K; Lin WC; Paoletti E; Plotkin S
    Vaccine; 1991 Sep; 9(9):631-7. PubMed ID: 1659051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
    Cranmer LD; Clark C; Spector DH
    Virology; 1994 Dec; 205(2):417-29. PubMed ID: 7975245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog.
    Messerle M; Keil GM; Schneider K; Koszinowski UH
    Virology; 1992 Nov; 191(1):355-67. PubMed ID: 1329325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the glycoprotein H gene of murine cytomegalovirus.
    Xu J; Dallas PB; Lyons PA; Shellam GR; Scalzo AA
    J Gen Virol; 1992 Jul; 73 ( Pt 7)():1849-54. PubMed ID: 1321219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus.
    Scalzo AA; Forbes CA; Davis-Poynter NJ; Farrell HE; Lyons PA
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2895-901. PubMed ID: 7595401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein.
    Kropff B; Mach M
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1999-2007. PubMed ID: 9267000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene.
    Schleiss MR
    Virology; 1994 Jul; 202(1):173-85. PubMed ID: 8009831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.
    Spaete RR; Thayer RM; Probert WS; Masiarz FR; Chamberlain SH; Rasmussen L; Merigan TC; Pachl C
    Virology; 1988 Nov; 167(1):207-25. PubMed ID: 2460994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).
    Britt WJ; Vugler L; Stephens EB
    J Virol; 1988 Sep; 62(9):3309-18. PubMed ID: 2841483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus.
    Xu J; Scalzo AA; Lyons PA; Farrell HE; Rawlinson WD; Shellam GR
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3235-40. PubMed ID: 7964634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
    Cranage MP; Smith GL; Bell SE; Hart H; Brown C; Bankier AT; Tomlinson P; Barrell BG; Minson TC
    J Virol; 1988 Apr; 62(4):1416-22. PubMed ID: 2831402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.